Key Quantitative Figures
The Investment Committee approved the following investment limits from the company's internal accruals:
- Government Securities, Treasury Bills, Government Bonds, NCDs, Commercial Papers and Other Debt Securities: ₹10,00,00,000 (Ten Crore)
- Listed equity shares and Mainboard/SME IPOs: ₹2,00,00,000 (Two Crore)
- Private Credit Funds, AIFs, Structured Debt Instruments: ₹15,00,00,000 (Fifteen Crore)
- Invoice discounting platforms and other investment opportunities: ₹3,00,00,000 (Three Crore)
- SIPs in Mutual Funds (Equity and Debt-Oriented Schemes): ₹3,00,00,000 (Three Crore)
Total approved investment framework: ₹33,00,00,000 (Thirty-Three Crore)
Dates of Action
The Investment Committee meeting was held on August 08, 2026. The disclosure was filed on the same date.
Parties Involved
The decision was made by the company's Investment Committee. The disclosure was signed by Anshu Anshuman, Company Secretary and Compliance Officer (ACS65515).
Purpose and Rationale
The company is implementing a hybrid treasury strategy to optimize surplus cash while maintaining safety and operational liquidity. The primary base will remain in traditional Bank Fixed Deposits for safety, with a measured portion allocated to capture higher post-tax, risk-adjusted returns on excess capital.
Transaction Details
The investment does not involve any related party transaction. All investments will be made from the company's internal accruals.
Additional Information
The disclosure is available on the company's website at www.amwillhealthcare.com.